Johnson & Johnson has announced sales of $17.8 billion for the second quarter of 2015, representing an 8.8 percent drop versus the second quarter of 2014. International sales decreased by 14.3 percent while domestic sales decreased by 2.4 percent. On an operational basis, excluding the net impact of acquisitions and divestitures, worldwide sales increased 1.7 percent, with an increase of 0.6 percent for domestic sales and international sales up 2.7 percent. The company posted net earnings of $4.5 billion for the current second quarter, which included after-tax intangible amortization expense of around $0.2 billion and a charge for after-tax special items of around $0.1 billion. Excluding after-tax intangible amortization expense and special items, adjusted net earnings were $4.8 billion, representing a decrease of 6.3 percent as compared to the second quarter in 2014. Vision care sales worldwide dropped 8.6 percent to $646 million as compared to second quarter results in 2014. Primary contributors to the company's operational growth in the vision care business were sales of contact lenses.